000 06019cam a2200661Ma 4500
005 20250919085807.0
006 m o d
007 cr cn|||||||||
008 161221s2012 enka ob 001 0 eng d
020 _a9780123979117
_q(electronic bk.)
020 _a0123979110
_q(electronic bk.)
020 _z9780123979001
029 1 _aCHBIS
_b010355681
029 1 _aDEBSZ
_b405346549
029 1 _aDEBSZ
_b431283451
029 1 _aNZ1
_b15831221
035 _a(OCoLC)823732498
_z(OCoLC)823387491
_z(OCoLC)823725870
035 _a(OCoLC)ocn823732498
039 9 _y12-21-2016
_zhafiz
_wmetacoll.MYUKM.updates.D20160920.T210208.sdallbooks.1 (perolehan)hafizupload21122016.mrc
_x48
040 _aE7B
_beng
_epn
_cE7B
_dOCLCQ
_dOCLCO
_dYDXCP
_dOPELS
_dNST
_dTFW
_dOCLCF
_dEBLCP
_dMHW
_dUKDOC
_dDEBSZ
_dOCLCQ
049 _aMAIN
050 4 _aQL757
_b.A38 2012eb
072 7 _aSCI
_x070000
_2bisacsh
082 0 4 _a591.7/857
_223
245 0 0 _aAdvances in parasitology
_nVolume eighty,
_p[The epidemiology of plasmodium vivax :
_bhistory, hiatus and hubris. Part A] /
_cedited by S.I. Hay, Ric Price, Kevin J. Baird.
250 _a1st ed.
260 _aKidlington, Oxford :
_bElsevier,
_c2012.
300 _a1 online resource (x, 356 pages) :
_bcolor illustrations.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aAdvances in parasitology,
_x0065-308X ;
_vv. 80
504 _aIncludes bibliographical references and index.
505 0 _aFront Cover; Series Editors; Editorial Board; Advances in Parasitology; Copyright; Contents; Contributors; Preface; Chapter One -- The Global Public Health Significance of Plasmodium vivax;?1. INTRODUCTION;?2. THE GLOBAL DISTRIBUTION OF P. VIVAX INFECTIONS;?3. SPATIAL DISTRIBUTION OF P. VIVAX MALARIA, POPULATIONS AT RISK AND ITS VECTORS;?4. REGIONAL SUMMARIES OF THE PUBLIC HEALTH SIGNIFICANCE OF P. VIVAX MALARIA;?5. DISCUSSION;?6. METHODS;?LIST OF ABBREVIATIONS; ACKNOWLEDGEMENTS; REFERENCES; Chapter Two -- Relapse;?1. INTRODUCTION;?2. HISTORY;?3. PHENOTYPIC VARIATION IN P. VIVAX.
505 8 _a4. RELAPSE DETERMINANTS?5. GEOGRAPHIC DISTRIBUTION OF RELAPSE PHENOTYPES;?6. THE EFFECTS OF AGE AND IMMUNITY ON RELAPSE;?7. DRUG EFFECTS ON RELAPSE;?8. VIVAX MALARIA FOLLOWING FALCIPARUM MALARIA;?9. THE PERIODICITY OF RELAPSE;?10. IMPLICATIONS FOR EPIDEMIOLOGICAL ASSESSMENT; ACKNOWLEDGEMENTS; REFERENCES; Chapter Three -- Plasmodium vivax: Clinical Spectrum, Risk Factors and Pathogenesis;?1. INTRODUCTION;?2. PRE-PATENT AND INCUBATION PERIODS;?3. SYMPTOMS AND SIGNS OF VIVAX MALARIA;?4. CLINICAL ILLNESS REQUIRING HOSPITALISATION;?5. SEVERE MALARIA;?6. RISK OF SEVERE DISEASE AND DEATH.
505 8 _a7. VULNERABLE GROUPS?8. SPECIFIC CLINICAL MANIFESTATIONS OF SEVERE VIVAX MALARIA;?9. SEVERE AND FATAL DISEASE RESULTING FROM TREATMENT WITH PRIMAQUINE;?10. RISK FACTORS FOR UNCOMPLICATED AND SEVERE VIVAX MALARIA;?11. PATHOPHYSIOLOGY OF DISEASE IN VIVAX MALARIA;?12. CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter Four -- Diagnosis and Treatment of Plasmodium vivax Malaria;?1. INTRODUCTION;?2. CHEMOTHERAPEUTICS TERMINOLOGY;?3. HISTORICAL PERSPECTIVES;?4. CHEMOPROPHYLAXIS AGAINST VIVAX MALARIA;?5. DIAGNOSIS OF VIVAX MALARIA;?6. TREATMENT OF UNCOMPLICATED VIVAX MALARIA.
505 8 _a7. TREATMENT OF SEVERE AND COMPLICATED VIVAX MALARIA?8. EVALUATING DRUG RESISTANCE IN VIVAX MALARIA;?9. RESEARCH AND DEVELOPMENT URGENCIES;?10. SUMMARY; REFERENCES; Chapter Five -- Chemotherapeutic Strategies for Reducing Transmission of Plasmodium vivax Malaria;?1. INTRODUCTION;?2. TRANSMISSION OF P. VIVAX;?3. REDUCING P. VIVAX TRANSMISSION BY TREATING SYMPTOMATIC DISEASE;?4. REDUCING P. VIVAX TRANSMISSION USING MASS DRUG ADMINISTRATION;?5. CONCLUSIONS; REFERENCES; Chapter Six -- Control and Elimination of Plasmodium vivax;?1. WHY CONTROLLING P. VIVAX IS DIFFICULT.
505 8 _a2. ESTABLISHED ANTI-TRANSMISSION MEASURES?3. DRUGS FOR CONTROL OF RELAPSING MALARIA;?4. DIFFICULTY GOING FROM LOW TO NO MALARIA TRANSMISSION;?5. SURVEILLANCE AS KEY INTERVENTION FOR MALARIA ELIMINATION;?6. PROBLEMS OF MALARIA REINTRODUCTION INTO ELIMINATED AREAS;?7. PROSPECTS FOR IMPROVED DRUGS FOR CONTROL/ELIMINATION;?8. PROSPECTS FOR IMPROVED ANTI-TRANSMISSION MEASURES;?9. CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES; INDEX.
520 _aFirst published in 1963, Advances in Parasitology contains comprehensive and up-to-date reviews in all areas of interest in contemporary parasitology. Advances in Parasitology includes medical studies on parasites of major influence, such as Plasmodium falciparum and trypanosomes. The series also contains reviews of more traditional areas, such as zoology, taxonomy, and life history, which shape current thinking and applications. Eclectic volumes are supplemented by thematic volumes on various topics, including control of human parasitic diseases and global mapping of infectious diseases. The 2010 impact factor is1.683. * Informs and updates on all the latest developments in the field * Contributions from leading authorities and industry experts.
590 _aElsevier
_bScienceDirect All Books
650 0 _aParasitology.
650 4 _aMedical parasitology.
650 7 _aSCIENCE
_xLife Sciences
_xZoology
_xGeneral.
_2bisacsh
650 7 _aParasitology.
_2fast
_0(OCoLC)fst01053186
655 4 _aElectronic books.
700 1 _aHay, S. I.
_q(Simon I.)
700 1 _aPrice, Ric.
700 1 _aBaird, J. Kevin.
776 0 8 _iPrint version:
_aPrice, Ric.
_tEpidemiology of Plasmodium Vivax: History, Hiatus and Hubris.
_dBurlington : Elsevier Science, ò012
_z9780123979001
830 0 _aAdvances in parasitology ;
_vv. 80.
_x0065-308X
856 4 0 _uhttp://ezplib.ukm.my/login?url=http://www.sciencedirect.com/science/bookseries/0065308X/80
907 _a.b16399663
_b2021-06-25
_c2019-11-12
942 _n0
914 _avtls003614071
998 _ae
_b2016-08-12
_cm
_dz
_feng
_genk
_y0
_z.b16399663
999 _c613354
_d613354